| Primary |
| Drug Use For Unknown Indication |
27.2% |
| Hypertension |
12.6% |
| Cardiac Failure Congestive |
8.6% |
| Depression |
6.6% |
| Product Used For Unknown Indication |
6.6% |
| Pain |
6.0% |
| Atrial Fibrillation |
4.6% |
| Emphysema |
4.0% |
| Cardiac Failure |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Breakthrough Pain |
2.0% |
| Fluid Overload |
2.0% |
| Hyperinsulinaemia |
2.0% |
| Joint Swelling |
2.0% |
| Left Ventricular Failure |
2.0% |
| Oedema |
2.0% |
| Phantom Pain |
2.0% |
| Schizoaffective Disorder |
2.0% |
| Arrhythmia |
1.3% |
| Cardiac Failure Chronic |
1.3% |
|
| Somnolence |
9.1% |
| Wheezing |
9.1% |
| Coronary Artery Bypass |
6.8% |
| Hyperglycaemia |
6.8% |
| Renal Failure |
6.8% |
| Ventricular Tachycardia |
6.8% |
| Vomiting |
6.8% |
| Burning Sensation |
4.5% |
| Pemphigoid |
4.5% |
| Renal Failure Acute |
4.5% |
| Respiratory Failure |
4.5% |
| Road Traffic Accident |
4.5% |
| Stridor |
4.5% |
| Tachycardia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Angioedema |
2.3% |
| Aortic Dissection |
2.3% |
| Colitis Ulcerative |
2.3% |
| Dissociation |
2.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
33.3% |
| Product Used For Unknown Indication |
15.5% |
| Hypertension |
8.1% |
| Depression |
5.1% |
| Diabetes Mellitus |
5.1% |
| Emphysema |
4.2% |
| Atrial Fibrillation |
4.0% |
| Asthma |
3.1% |
| Immunosuppressant Drug Therapy |
3.0% |
| Cardiac Failure |
2.5% |
| Pain |
2.3% |
| Cardiac Failure Congestive |
2.0% |
| Type 2 Diabetes Mellitus |
1.8% |
| Bacteraemia |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Antifungal Prophylaxis |
1.4% |
| Arrhythmia |
1.4% |
| Arthritis |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Cardiovascular Disorder |
1.1% |
|
| Tubulointerstitial Nephritis |
13.4% |
| Renal Failure Acute |
12.6% |
| Ventricular Tachycardia |
10.1% |
| Tonic Convulsion |
8.4% |
| Toxic Epidermal Necrolysis |
6.7% |
| Somnolence |
5.9% |
| Neuroleptic Malignant Syndrome |
5.0% |
| Lactic Acidosis |
4.2% |
| Tension |
4.2% |
| Completed Suicide |
3.4% |
| Renal Failure Chronic |
3.4% |
| Renal Impairment |
3.4% |
| Vomiting |
3.4% |
| Wheezing |
3.4% |
| Hypoglycaemia |
2.5% |
| Pancreatitis Haemorrhagic |
2.5% |
| Pneumonia Pneumococcal |
2.5% |
| Complex Partial Seizures |
1.7% |
| Coronary Artery Bypass |
1.7% |
| Mesenteric Artery Stenosis |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.3% |
| Product Used For Unknown Indication |
17.0% |
| Rheumatoid Arthritis |
8.9% |
| Hypertension |
7.2% |
| Pain |
4.3% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Diabetes Mellitus |
3.3% |
| Atrial Fibrillation |
3.1% |
| Prophylaxis |
2.6% |
| Diffuse Large B-cell Lymphoma |
2.5% |
| Cardiac Failure |
2.4% |
| Myocardial Infarction |
2.2% |
| Hepatic Neoplasm Malignant |
1.9% |
| Non-hodgkin's Lymphoma |
1.9% |
| Myocardial Ischaemia |
1.9% |
| Coronary Artery Disease |
1.9% |
| Angina Pectoris |
1.8% |
| Cardiovascular Event Prophylaxis |
1.7% |
| Constipation |
1.5% |
| Infection |
1.5% |
|
| Vomiting |
10.8% |
| Renal Failure |
8.8% |
| Renal Failure Acute |
7.7% |
| Rhabdomyolysis |
7.7% |
| Renal Impairment |
7.1% |
| Weight Decreased |
5.7% |
| Weight Increased |
5.3% |
| Death |
5.1% |
| Pulmonary Oedema |
5.1% |
| Sepsis |
5.1% |
| Pneumonia |
4.5% |
| Thrombocytopenia |
3.5% |
| Myocardial Infarction |
3.3% |
| Ascites |
3.1% |
| Dyspnoea |
3.1% |
| Fall |
3.1% |
| Syncope |
3.1% |
| International Normalised Ratio Increased |
2.9% |
| Myocardial Ischaemia |
2.6% |
| Respiratory Failure |
2.6% |
|
| Interacting |
| Fallot's Tetralogy |
62.1% |
| Product Used For Unknown Indication |
17.2% |
| Hyperinsulinism |
13.8% |
| Hyperinsulinaemia |
3.4% |
| Hypoglycaemia |
3.4% |
|
| Hyperglycaemia |
75.0% |
| Hyponatraemia |
12.5% |
| Renal Failure Acute |
12.5% |
|
